Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS

Azamian Bobak R. sold 10,000 Tarsus Pharmaceuticals, Inc. shares (Form 4)

Traded Jun 17, 2026 · Filed Jun 22, 2026

On Jun 17, 2026, Azamian Bobak R. (Director, President/CEO and Board Chair) sold 10,000 Tarsus Pharmaceuticals, Inc. shares at an average US$61.55 for US$615K under a trading plan, leaving 847,991 shares. Filed Jun 22, 2026 (Form 4).

Sold
10,000 shares
Price
US$61.55 average (US$61.24 to US$61.81)
Value
US$615K
Holding after
847,991 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President/CEO and Board Chair

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Common StockSale4,582US$61.24853,409Indirect
Jun 17, 2026Common StockSale5,418US$61.81847,991Indirect

Source

View original at SEC

Related